SCHEMBL5097601

SCHEMBL5097601

Cc1cc(C(=O)NC2(C(=O)O)CCCCC2)oc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
TAS1R3 Q7RTX0 2/20 0.46
TAS1R1 Q7RTX1 2/20 0.46
MITF O75030 1/20 0.45
TP53 P04637 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
AKR1C3 P42330 1/20 0.44
CNR2 P34972 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PYGL P06737 5/20 0.42
CYP2C9 P11712 1/20 0.42
CNR1 P21554 1/20 0.42
ERAP1 Q9NZ08 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5105697 0.78 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL1840233 0.74 RAB9A (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL5101564 0.74 POLB (0.55) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL5098012 0.71 MAPT (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL5098144 0.71 LMNA (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL1837001 0.71 KDM4E (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1TAS1R3
SCHEMBL1843420 0.71 KDM4E (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL5600447 0.69 L3MBTL1 (0.55) NPC1RAB9AALDH1A1TAS1R3TAS1R1
SCHEMBL14086112 0.69 NPC1 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL13164041 0.69 PYGL (0.54) HPGDPYGLCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP NPC1 729/4885RAB9A 2273/4885SMN1; SMN2 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.